Mohsin Shah, MBBS, MSCE

Associate Director, Global Integrated Evidence - Epidemiology & RWE Oncology
Boehringer Ingelheim Pharmaceuticals, Inc

Poster(s):

• (B-007) Updated Trends in incidence, prevalence, and survival in patients with Head and Neck Squamous Cell Carcinoma in the United States
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET